Literature DB >> 16183409

An adult with acute poststreptococcal glomerulonephritis complicated by hemolytic uremic syndrome and nephrotic syndrome.

Tomoko Izumi1, Toshitake Hyodo, Yuichi Kikuchi, Toshihiko Imakiire, Tatsuyoshi Ikenoue, Shigenobu Suzuki, Nobuyuki Yoshizawa, Soichiro Miura.   

Abstract

We report the case of a 47-year-old man with the simultaneous occurrence of clinical and laboratory features consistent with acute poststreptococcal glomerulonephritis (APSGN), hemolytic uremic syndrome (HUS), and nephrotic syndrome. Acute nephritic syndrome occurred 3 weeks after having pharyngeal pain and diarrhea. He presented with edema and hypertension on admission. Laboratory evaluation showed hemolytic anemia with fragmentation, thrombocytopenia, elevated lactic dehydrogenase level, low haptoglobin level, low complement C3 level, and elevated antistreptolysin-O titer. Serum creatinine level was 1.22 mg/dL (108 micromol/L), and urinalysis showed marked proteinuria, with protein of 8.7 g/d, and hematuria. The renal biopsy specimen was characteristic of APSGN, but not HUS. Moderate expansion of the mesangial matrix, moderate proliferation of epithelial and endothelial cells, and marked infiltration of neutrophils was seen by means of light microscopy, and many subepithelial humps were seen by means of electron microscopy. Neither fibrin deposition nor evidence of thrombotic microangiopathy was found. Complement C3 deposition along the capillary wall and tubules was seen in an immunofluorescence study. The patient was administered plasma infusion at 320 mL/d and antihypertensive drugs. Serum complement C3 and haptoglobin levels returned to normal within 3 weeks. This is a rare case of the simultaneous occurrence of APSGN, HUS, and nephrotic syndrome.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183409     DOI: 10.1053/j.ajkd.2005.06.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Systemic infections mimicking thrombotic thrombocytopenic purpura.

Authors:  Kristina K Booth; Deirdra R Terrell; Sara K Vesely; James N George
Journal:  Am J Hematol       Date:  2011-09       Impact factor: 10.047

Review 2.  Autoimmunity in Acute Poststreptococcal GN: A Neglected Aspect of the Disease.

Authors:  Bernardo Rodriguez-Iturbe
Journal:  J Am Soc Nephrol       Date:  2021-02-02       Impact factor: 10.121

Review 3.  Podocyte dysfunction in atypical haemolytic uraemic syndrome.

Authors:  Marina Noris; Caterina Mele; Giuseppe Remuzzi
Journal:  Nat Rev Nephrol       Date:  2015-01-20       Impact factor: 28.314

4.  Periodic fever syndrome with relapsing glomerulonephritis: a case report and teaching points.

Authors:  Mykola V Tsapenko; Timothy G Call; John A Lust; Nelson Leung
Journal:  NDT Plus       Date:  2011-07-06

5.  Thrombotic microangiopathy with transiently positive direct Coombs test in an adult with poststreptococcal acute glomerulonephritis: a case report.

Authors:  Dan Inoue; Takashi Oda; Sachiko Iwama; Takahiko Hoshino; Mitsuya Mukae; Takashi Sakai; Aki Kojima; Takahiro Uchida; Tadasu Kojima; Kentaro Sugisaki; Tomohiro Tomiyasu; Noriko Yoshikawa; Muneharu Yamada
Journal:  BMC Nephrol       Date:  2022-02-05       Impact factor: 2.388

6.  Atypical presentation of post infectious glomerulonephritis as malignant hypertension and thrombotic microangiopathy.

Authors:  M Vankalakunti; P Malleshappa; H Hussain; A Marilingegouda
Journal:  Indian J Nephrol       Date:  2014-03

7.  Post-streptococcal glomerulonephritis associated with atypical hemolytic uremic syndrome: to treat or not to treat with eculizumab?

Authors:  Aadil Kakajiwala; Tricia Bhatti; Bernard S Kaplan; Rebecca L Ruebner; Lawrence Copelovitch
Journal:  Clin Kidney J       Date:  2015-11-26

8.  Nephrotic-range proteinuria and central nervous involvement in typical hemolytic uremic syndrome: a case report.

Authors:  Chuan Shi; Chao Li; Wei Ye; Wen-Ling Ye; Ming-Xi Li
Journal:  BMC Nephrol       Date:  2020-07-31       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.